
Can Hyperbaric Oxygen Therapy (HBOT) Improve Capacity in ME/CFS?
Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% oxygen in a pressurized chamber, typically at 1.5 to 2.5 times normal atmospheric pressure. These conditions permit a significant increment of the oxygen supply to blood and to tissues even without the contribution from hemoglobin. This may aid in conditions where improving oxygen delivery can support recovery.
It is hypothesised that, through its effect, HBOT may elicits a cascade of cellular responses that collectively may address many pathophysiological aspects of ME/CFS.